[2] Any patient presenting with suspected semaglutide overdose should undergo clinical assessment including vital signs, hydration status, blood glucose monitoring, and consideration of serum electrolytes and renal function
Available at: Orforglipron (Foundayo) A Second Oral GLP-1 Receptor Agonist for Weight Loss
The large-scale SELECT trial demonstrated that semaglutide reduced major adverse cardiovascular events by 20% 13
Tirzepatide (branded as Mounjaro) is FDA-approved and targets GLP-1 and GIP receptors
renal function should be monitored if persistent vomiting or diarrhoea occurs Individuals with eating disorders or a history of disordered eating : Significant appetite suppression may exacerbate underlying psychological relationships with food Healthcare professionals should conduct a thorough medical history and risk assessment before enrolling patients in trials or, in future, prescribing retatrutide
Discover the right way to approach dosing, what to do about all the side effects people talk about, and more